Stay connected
The head of the German vaccine regulator has said that surely teams of other people living in Germany will possibly get vaccinated early next year in opposition to the coronavirus that has killed another 800,000 people worldwide and is wreaking havoc on the economy. world.
More than a dozen international drug brands are conducting complex clinical trials, each with tens of thousands of participants, and many are waiting to find out if their COVID-19 vaccines are working and are through until the end of this year.
Klaus Cichutek, director of the Paul Ehrlich Institute, told the Funke newspaper organization that knowledge of the phase I and phase II trials showed that certain vaccines triggered an immune reaction opposite to the coronavirus.
“If knowledge of Phase III trials shows that vaccines are effective and safe, the first vaccines can be approved at the beginning of the year, in all likelihood under certain conditions,” he said.
“According to manufacturers’ assurances, the first doses for others in Germany will be obtained at that time, in accordance with the priorities set out through the Standing Committee on Immunization,” Cichutek said, referring to the organization that makes recommendations for vaccine use in Germany.
Infections in Germany have increased in recent weeks and knowledge from the Robert Koch Institute of Infectious Diseases (RKI) on Wednesday showed that the number of cases shown of coronavirus soared from 1,510 to 226,914.
The RKI stated that 39% of cases were likely to be imported at most, and that Kosovo, Turkey and Croatia were the maximum reported as the maximum likely source of infection in recent weeks.
Several companies, in addition to Moderna, AstraZeneca and Pfizer Inc, say they plan to manufacture more than one billion doses of a vaccine next year.
German biotechnology company CureVac has regulated an immediate approval procedure for its long-term vaccine and plans to bring it to market until mid-2021.
Russia said its vaccine would be deployed until the end of the month.
Do you have any confidential information? We want to hear from you.
Sign up for loose newsletters and get more CNBC in your inbox
Get it in your inbox and more information about our services.
© 2020 CNBC LLC. All rights are reserved. An NBCUniversal department
Knowledge is a real-time snapshot: data is delayed for at least 15 minutes, global industry and monetary news, inventory prices, knowledge, and market analysis.
Data also by